Is necroinflammation a prerequisite for fibrogenesis?

Hepato-Gastroenterology

Volumn 43, Issue 7, 1996, Pages 104-120

  Day, C P ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Adducts; Alcoholic liver disease; Fibrogenesis; Iron overload; Lipid peroxidation; Oxidative stress; Reactive oxygen species

Indexed keywords

COLLAGEN; DESMIN; LACTIC ACID; REACTIVE OXYGEN METABOLITE; RETINOL;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; CELL PROLIFERATION; FIBROGENESIS; HEMOCHROMATOSIS; HUMAN; IRON OVERLOAD; ITO CELL; LIPID PEROXIDATION; LIVER FIBROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; STELLATE CELL;

ACETALDEHYDE; ETHANOL; HEMOCHROMATOSIS; HUMANS; INFLAMMATION; LACTATES; LIPID PEROXIDATION; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; NECROSIS; VITAMIN A DEFICIENCY;

EID: 0029994948     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (155)

1. Blomhoff R, Wake K: Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. [Review]. FASEB J. 1991; 5: 271-277.
2. Burt AD: CL Oakley Lecture (1993). Cellular and molecular aspects of hepatic fibrosis. J. Pathol. 1993; 170: 105-114.
3. Geerts A, Vrijsen R, Rauterberg J, Burt A, Schellink P, Wisse E: In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. J. Hepatol. 1989; 9: 59-68.
4. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM: Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J. Biol. Chem. 1989; 264: 10756-10762.
5. Johnson SJ, Hines JE, Burt AD: Macrophage and perisinusoidal cell kinetics in acute liver injury. J. Pathol. 1992; 166: 351-358.
6. Hines JE, Johnson SJ, Burt AD: In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. Am. J. Pathol. 1993; 142: 511-518.
7. Mathew J, Hines JE, James OF, Burt AD: Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury. J. Hepatol. 20 (1994) 537-541
8. Friedman SL, Arthur MJP: Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J. Clin. Invest. 1989; 84: 1780-1785.
9. Friedman SL: Cellular sources of collagen and regulation of collagen production in liver. [Review]. Semin. Liver Dis. 1990; 10: 20-29.
10. Matsuoka M, Pham NT, Tsukamoto H: Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 1989; 9: 71-78.
11. Bachem MG, Sell KM, Melchior R, Kropf J, Eller T, Gressner AM: Tumor necrosis factor alpha (TNF-a) and transforming growth factor β1 (TCF-β1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virchows Arch. B Cell Pathol. 1993; 63: 123-130.
12. Pinzani M, Gentilini A, Caligiuri A, De Franco R, Pellegrini G, Milani S, Marra F, Gentilini P: Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells. Hepatology 1995; 21: 232-239.
13. Winwood PJ, Arthur MJP: Kupffer cells: their activation and role in animal models of liver injury and human liver disease. Semin. Liver Dis. 1993; 13: 50-59.
14. Mallat A, Fouassier L, Preaux AM, Serradeil-Le Gal C, Rosenbaum J, Dhumeaux D, Mavier P, Lolersztajn S: Endothelin-1 inhibits proliferation of human myofibroblastic Ito cells. J. Hepatol. 1994; 21(Suppl 1): S8
15. Mallat A, Preaux A, Blazejewski S, Rosenbaum J, Dhumeaux D, Mavier P: Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 1995; 21: 1003-1010.
16. Gressner AM, Lotfi S, Gressner G, Lahme B: Identification and partial characterization of a hepatocyte-derived factor promoting proliferation of cultured fat-storing cells (parasinusoidal lipocytes). Hepatology 1992;16:1250-1266
17. Lelbach WK: Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. [Review]. Ann. N.Y. Acad. Sci. 1975; 252: 85-105.
18. Lieber CS, DeCarli L, Rubin E: Sequential production of fatty liver, hepatitis, and cirrhosis in sub-human primates fed ethanol with adequate diets. Proc. Natl. Acad. Sci. USA 1975; 72: 437-441.
19. Tsukamoto H, Towner SJ, Ciofalo LM, French SW: Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology 1986; 6: 814-822.
20. Van Waes L, Lieber CS: Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury. Gastroenterology 1977; 73: 646-650.
21. Nakano M, Worner TM, Lieber CS: Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. Gastroenterology 1982; 83: 777-785.
22. Schaffner F, Popper H: Capillarization of hepatic sinusoids in man. Gastroenterology 1963; 44: 239-242.
23. Pequignot G, Tuyns AJ, Berta JL: Ascitic cirrhosis in relation to alcohol consumption. Int. J. Epidemiol. 1978; 7: 113-120.
24. Day CP, Bassendine MF: Genetic predisposition to alcoholic: liver disease. [Review]. Gut 1992; 33: 1444-1447.
25. Marbet UA, Bianchi L, Meury U, Stalder GA: Long-term histological evaluation of the natural history and prognostic factors of alcoholic: liver disease. J. Hepatol. 1987; 4: 364-372.
26. Galambos JT: Natural history of alcoholic hepatitis. III. Histological changes. Gastroenterology 1972; 63: 1026-1035.
27. MacSween RM, Burt AD: Histologic spectrum of alcoholic liver disease. [Review]. Semin. Liver Dis. 1986; 6: 221-232.
28. Worner TM, Lieber CS: Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 1985; 254: 627-630.
29. Teli MR, Day CP, Burt AD, James OFW: Pattern of steatosis and continued drinking predict risk of progression to cirrhosis in pure alcoholic fatty liver. Hepatology 1994; 20: 319A.
30. Takada A, Nei J, Matsuda Y, Kanayama R: Clinicopathological study of alcoholic fibrosis. Am. J. Gastroenterol. 1982; 77: 660-666.
31. Pares A, Caballeria J, Bruguera M, Torres M, Rodes J: Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J. Hepatol. 1986; 2: 33-42.
32. Sorensen TI, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P: Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984; 2: 241-244.
33. Mak KM, Leo MA, Lieber CS: Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology 1984; 87: 188-200.
34. Okanoue T, Burbige EJ, French SW: The role of the Ito cell in perivenular and intralobular fibrosis in alcoholic hepatitis. Arch. Pathol. Lab. Med. 1983; 107: 459-463.
35. Horn T, Junge J, Christoffersen P: Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space. J. Hepatol. 1986; 3: 333-340.
36. Mak KM, Lieber CS: Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology 1988; 8: 1027-1033.
37. Reeves HL, Burt AD, Wood S, James OFW, Day CP: Lipocyte activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. Hepatology 1994; 20: 318A.
38. Bacon BR, Britton RS: The pathology of hepatic iron overload: a free radical-mediated process? [Review]. Hepatology 1990; 11: 127-137.
39. Powell LW: Haemochromatosis and related iron storage diseases. In: Millward-Sadler, G.H., R. Wright, M.J.P. Arthur (Eds.); Wright's Liver and Biliary Diseases. 3rd Edition, pp. 976-979. WB Saunders Co Ltd (1992)
40. Bassett ML, Halliday JW, Powell LW: Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6: 24-29.
41. Chang HY, Robbins SL, Mallory GK: Prolonged intravenous administration of iron to normal and anemic rabbits. Lab. Invest. 1959; 8: 1-18.
42. Lisboa PE: Experimental hepatic cirrhosis in dogs caused by chronic massive iron overload. Gut 1971; 12: 363-368.
43. Brissot P, Campion JP, Guillouzo A, Allain H, Messner M, Simon M, Ferrand B, Bourel M: Experimental hepatic iron overload in the baboon; results of a two-year study. Evolution of biological and morphologic hepatic parameters of iron overload. Dig. Dis. Sci. 1983; 28: 616-624.
44. Park CH, Bacon BR, Brittenham GM, Tavill AS: Pathology of dietary iron overload in rats. Lab. Invest. 1987; 57: 555-563.
45. Iancu TC: Iron overload. [Review]. Mol. Aspects Med. 1983; 6: 1-100.
46. Houglum K, Bedossa P, Chojkier M: TGF-β and collagen-a1(I)) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am. J. Physiol. 1994; 267 : 0908-913
47. Weintraub LR, Goral A, Grasso J, Franzblau C, Sullivan A, Sullivan S: Pathogenesis of hepatic fibrosis in experimental iron overload. Br. J. Haematol. 1985; 59: 321-331.
48. Finch SC, Finch CA: Idiopathic hemochromatosis: an iron storage disease. Medicine 1955; 34: 381-430.
49. Ramm GA, Li SCY, Li L, Britton RS, O'Neill R, Kobayashi Y, Bacon BR: (Chronic iron overload causes activation of rat lipocytes in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 1995; 268: G451-G458.
50. Rosser BG, Gores GJ: Liver cell necrosis: cellular mechanisms and clinical implications. [Review]. Gastroenterology 1995; 108: 252-275.
51. Shiratori Y, Ichida T, Kawase T, Wisse E: Effect of acetaldehyde on collagen synthesis by fat-storing cells isolated from rats treated with carbon tetrachloride. Liver 1986; 6: 246-251.
52. Moshagem H, Casini A, Lieber CS: Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 1990; 12: 511-518.
53. Casini A, Cunningham M, Rojkind M, Lieber CS: Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991; 13: 758-765.
54. Savolainen ER, Leo MA, Timpl R, Lieber CS: Acetaldehyde and lactate stimulate collagen synthesis of cultured baboon liver myofibroblasts. Gastroenterology 1984; 87: 777-787.
55. Holt K, Bennett M, Chojkier M: Acetaldehyde stimulates collagen and noncollagen protein production by human fibroblasts. Hepatology 1984; 4: 843-848.
56. Brenner DA, Chojkier M: Acetaldehyde increases collagen gene transcription in cultured human fibroblasts. J. Biol. Chem. 1987; 262: 17690-17695.
57. Jennett RB, Tuma DJ, Sorrell MF: Effects of acetaldehyde on hepatic proteins. [Review]. Prog. Liver Dis. 1990; 9: 325-333.
58. Casini A, Galli G, Salzano R, Rotella CM, Surrenti C: Acetaldehyde-protein adducts, but not lactate and pyruvate, stimulate gene transcription of collagen and fibronectin in hepatic fat-storing cells. J. Hepatol. 1993; 19: 385-392.
59. Holstege A, Bedossa P, Poynard T, Kollinger M, Chaput JC, Houglum K, Chojkier M: Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis. Hepatology 1994; 19: 367-374.
60. Tsukamoto H, Niemela O, Parkkila S, Yla-Herttuala S, Brittenham G: Acetaldehyde, malondialdehyde, and 4-hydroxynonenal adducts and Ito cell activation in iron potentiated alcoholic liver fibrosis. Hepatology 1994; 20: 314A.
61. Niemela O, Parkkila S, Yla-Herttuala S, Villanueva J, Halsted CH: Sequential acetaldehyde production and lipid peroxidation in a micropig model of alcoholic liver disease. Hepatology 1994; 20: 314A.
62. Casini A, Galli G, Salzano R, Ceni E, Franceschelli F, Rotella CM, Surrenti C: Acetaldehyde induces c-fos and c-jun proto-oncogenes in fat-storing cell cultures through protein kinase C activation. Alcohol Alcohol 1994; 29: 303-314.
63. 2+, phorbol esters, and ATP. J. Biol. Chem. 1985; 260: 15718-15722.
64. Niemela O, Mannermaa RM, Oikarinen J: Impairment of histone H1 DNA binding by adduct formation with acetaldehyde. Life Sci. 1990; 47: 2241-2249.
65. Wu CH, Walton CM, Wu GY: Propeptide-mediated regulation of procollagen synthesis in IMR-90 human lung fibroblast cell cultures. J. Biol. Chem. 1991;266:2983-2987.
66. Korsten MA, Matsuzaki S, Feinman L, Lieber CS: High blood acetaldehyde levels after ethanol administration. Difference between alcoholic and nonalcoholic subjects. N. Engl. J. Med. 1975; 292: 386-389.
67. Peters TJ, Ward RJ: Role of acetaldehyde in the pathogenesis of alcoholic liver disease. [Review]. Mol. Aspects Med. 1988; 10: 179-190.
68. Ueshima Y, Matsuda Y, Wang BY, Takase S, Takada A: Ethanol and acetaldehyde metabolism in cultured rat hepatocytes. Alcohol Alcohol 1993; 28 (Suppl 1A): 3-10
69. Gressner AM, Althaus M: Effects of ethanol, acetaldehyde, and lactate on proteoglycan synthesis and proliferation of cultured rat liver fat-storing cells. Gastroenterology 1988; 94: 797-807.
70. Friedman SL: Acetaldehyde and alcoholic fibrogenesis: fuel to the fire, but not the spark. [Review]. Hepatology 1990; 12: 609-612.
71. Casini A, Ceni E, Salzano R, Milani S, Schuppan D, Surrenti C: Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells. Life Sci. 1994; 55: 1311-1316.
72. Arthur MJ, Friedman SL, Roll FJ, Bissell DM: Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J. Clin. Invest. 1989; 84: 1076-1085.
73. 4-induced liver injury in rats. Biochem. Biophys. Res. Commun. 1990; 173: 111-119.
74. Green H, Goldberg B: Collagen cell protein synthesis by an established mammalian fibroblast line. Nature 1964; 204: 347-9.
75. Cerbon-Ambriz J, Cerbon-Solorzano J, Rojkind M: Regulation of collagen production in freshly isolated cell populations from normal and cirrhotic rat liver: effect of lactate. Hepatology 1991; 13: 551-556.
76. 4H-hydroxyproline in liver slices of CC14 cirrhotic rats. Lab. Invest. 1987; 57: 392-396.
77. Shaw S, Worner TM, Lieber CS: Frequency of hyperprolinemia in alcoholic liver cirrhosis: relationship to blood lactate. Hepatology 1984; 4: 295-299.
78. Senoo HH, Wake K: Suppression of experimental hepatic fibrosis by administration of vitamin A. Lab. Invest. 1985; 52: 182-194.
79. Davis BH, Vucic A: The effect of retinol on Ito cell proliferation in vitro. Hepatology 1988; 8: 788-793.
80. Leo MA, Lieber CS: Hepatic vitamin A depletion in alcoholic liver injury. N. Engl. J. Med. 1982; 307: 597-601.
81. Sato M, Lieber CS: Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats. J. Nutr. 1981; 111: 2015-2023.
82. Halliwell B: Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? [Review]. Lancet 1994; 344: 721-724.
83. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts L: A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA 1990; 87: 9383-9387.
84. Kass GE, Bellomo NG, Juedes MJ, Orrenius S: Toxic effects of calcium on mitochondria. Meth. Toxicol. 1993; 2: 378-388.
85. Babior BM, Woodman RC.: Chronic granulomatous disease. [Review]. Semin. Hematol. 1990; 27: 247-259.
86. Burk RF, Lane JM, Patel K: Relationship of oxygen and glutathione in protection against carbon tetrachloride-induced hepatic microsomal lipid peroxidation and covalent binding in the rat. Rationale for the use of hyperbaric oxygen to treat carbon tetrachloride ingestion. J. Clin. Invest. 1984; 74: 1996-2001.
87. Aust SD, Chgnell CF, Bray TM, Kalyanaraman B, Mason RP: Free radicals in toxicology. [Review]. Toxicol. Appl. Pharmacol. 1993; 120: 168-78.
88. Cederbaum AI: Role of lipid peroxidation and oxidative stress in alcohol toxicity. [Review]. Free Rad. Biol. Med. 1989; 7: 537-539.
89. Bacon BR, Tavill AS, Brittenham GM, Park CH, Recknagel RO: Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J. Clin. Invest. 1983; 71:429-439.
90. Sternlieb I: Copper and the liver. [Review]. Gastroenterology 1980; 78: 1615-1628.
91. Britton RS, O'Neill R, Bacon BR: Hepatic mitochondrial malondialdehyde metabolism in rats with chronic iron overload. Hepatology 1990; 11: 93-97.
92. Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M: Stimulation of collagen alpha 1(1) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 1994; 19: 1262-1271
93. Houglum K, Filip M, Witztum JL, Chojkier M: Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J. Clin. Invest. 1990; 86: 1991-1998.
94. Situnayake RD, Crump BJ, Thurnham DI, Davies JA, Gearty J, Davis M: Lipid peroxidation and antioxidants in alcoholic liver disease. Gut 1990; 31: 1311-1317.
95. Muller A, Sies H: Role of alcohol dehydrogenase activity and the acetaldehyde in ethanol-induced ethane and pentane production by isolated perfused rat liver. Biochem. J. 1982; 206: 153-156.
96. Kawase T, Kato S, Lieber CS: Lipid peroxidation and antioxidant defense systems in rat liver after chronic ethanol feeding. Hepatology 1989; 10: 815-821.
97. Wu D, Cederbaum AI: Presence of functionally active cytochrome P-450IIE1 in the plasma membrane of rat hepatocytes. Hepatology 1992; 15: 515-24.
98. Winston GW, Cederbaum AI: NADPH-dependent production of oxy radicals by purified components of the rat liver mixed function oxidase system. II. Role in microsomal oxidation of ethanol. J. Biol. Chem. 1983; 258: 1514-1519.
99. IRat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P450IIE1). Biochem. Pharmacol. 1989; 38: 1313-1319
100. Shaw S: Lipid peroxidation, iron mobilization and radical generation induced by alcohol. [Review]. Free Rad. Biol. Med. 1989; 7: 541-547.
101. Dicker E, Cederbaum AI: Generation of reactive oxygen species and reduction of ferric chelates by microsomes in the presence of a reconstituted system containing ethanol, NAD+ and alcohol dehydrogenase. Alcohol Clin. Exp. Res. 1990; 14: 238-244.
102. Kato S, Kawase T, Alderman J, Inatomi N, Lieber CS: Role of xanthine oxidase in ethanol-induced lipid peroxidation in rats. Gastroenterology 1990; 98: 203-210.
103. Shaw S, Jayatilleke E: The role of aldehyde oxidase in ethanol-induced hepatic lipid peroxidation in the rat. Biochem. J. 1990; 268: 579-583.
104. Albano E, Tomasi A, Goria-Gatti L, Dianzani MU: Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chem. Biol. Interact. 1988; 65: 223-234.
105. Albano E, Tomasi A, Persson JO, et al.: Role of ethanol-inducible cytochrome P450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem. Pharmacol. 1991; 41: 1895-1902
106. Clot P, Bellomo G, Tabone M, Arico S, Albano E: Detection of antibodies against proteins modified by hydroxyethyl free radicals in patients with alcoholic cirrhosis. Gastroenterology 1995; 108: 201-207.
107. Videla LA, Iturriaga H, Pino ME, Bunout D, Valenzuela A, Ugarte G: Content of hepatic reduced glutathione in chronic alcoholic patients: influence of the length of abstinence and liver necrosis. Clin. Sci. 1984; 66: 283-290.
108. Altomare E, Vendemiale G, Albano O: Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases. Life Sci. 1988; 43: 991-998.
109. Lieber CS, Casini A, DeCarli LM, Kim CI, Lowe N, Sasaki R, Leo MA: S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 1990; 11: 165-172.
110. Speisky H, MacDonald A, Giles G, Orrego H, Israel Y: Increased loss and decreased synthesis of hepatic glutathione after acute ethanol administration. Turnover studies. Biochem. J. 1985; 225: 565-572.
111. Lauterburg BH, Davies S, Mitchell JR: Ethanol suppresses hepatic glutathione synthesis in rats in vivo. J. Pharmacol. Exp. Ther. 1984; 230: 7-11.
112. Corrales F, Ochoa P, Rivas C, Martin-Lomas M, Mato JM, Pajares MA: Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction. Hepatology 1991; 14: 528-533.
113. Thurnham DI, Crump BJ, Davies JA, Situnayake RD, Davis M: Nutritional status of vitamins E,C and B2 in alcoholics in relation to the plasma phospholipid-2-esterified 9,11-linoleic acid: 9,12-linoleic acid value. Proc. Nutr. Soc. 1986; 45: 62A.
114. Bell H, Bjorneboe A, Eidsvoll B, Norum KR, Raknerud N, Try K, Thomassen Y, Drevon CA: Reduced concentration of hepatic alpha-tocopherol in patients with alcoholic liver cirrhosis. Alcohol Alcohol 1992; 27: 39-46.
115. Bjorneboe GE, Bjorneboe AA, Hagen RF, Morland J, Drevon CA: Reduced hepatic alpha-tocopherol content after longterm administration of ethanol to rats. Biochim. Biophys. Acta 1987; 918: 236-241.
116. Zidenberg-Cherr S, Olin KL, Villanueva J, Tang A, Phinney SD, Halsted CH, Keen CL: Ethanol-induced changes in hepatic free radical defense mechanisms and fatty-acid composition in the miniature pig. Hepatology 1991; 13: 1185-1192.
117. Keen CL, Tamura T, Lonnerdal B, Hurley LS, Halsted CH: Changes in hepatic superoxide dismutase activity in alcoholic monkeys. Am. J. Clin. Nutr. 1985; 41: 929-932.
118. Dworkin B, Rosenthal WS, Jankowski RH, Gordon GG, Haldea D: Low blood selenium levels in alcoholics with and without advanced liver disease. Correlations with clinical and nutritional status. Dig. Dis. Sci. 1985; 30: 838-844.
119. Day CP, Yeaman SJ: The biochemistry of alcohol-induced fatty liver. [Review]. Biochim. Biophys. Acta 1994; 1215: 33-48.
120. Girotti AW: Mechanisms of lipid peroxidation. [Review]. Free Rad. Biol. Med. 1985; 1: 87-95.
121. Chojkier M, Houglum K, Solis-Herruzo J, Brenner DA: Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation? J. Biol. Chem. 1989; 264: 16957-16962.
122. Beno DWA, Retsky JE, Davis KH: Lipid peroxidation-indnced isoprostane independently activates Ito cell MAP kinase and increases type I collagen mRNA abundance. Hepatology 1994; 20: 291A.
123. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, Gentilini P, Dianzani MU: Stimulation of lipid peroxidation or 4-bydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem. Biophys. Res. Commun. 1993; 194: 1044-50
124. Pietrangelo A, Gualdi R, Montosi G, Casalgrandi E, Ventura E: Iron as a paracrine activator of liver fat storing cells during experimental fibrosis. Hepatology 1994; 20: 290A.
125. Esterbauer H, Jurgens G, Quehenberger O, Koller E: Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 1987; 28: 495-509.
126. Casini A, Ceni E, Salzano R, Parola M, Galli A, Romano M, Surrenti C: Neutrophil-derived reactive oxygen species (ROS) induce lipid peroxidation and stimulate collagen synthesis in human fat-storing cells. Hepatology 1994; 20: 292A
127. Hussain MZ, Watson JA, Bhatnagar RS: Increased prolyl hydroxylase activity and collagen synthesis in hepatocyte cultures exposed to superoxide. Hepatology 1987; 7: 502-507.
128. Hernandez-Munoz I, de la Torre MP, Pedraza MA, Sanchez-Alcazar JA, Munoz-Yague MT, Solis-Herruzo JA: Toxic oil stimulates collagen synthesis acting at a pretranslational level in cultured fat-storing cells. Gastroenterology 1994; 106: 691-701.
129. Hrubec Z, Omenn GS: Evidence of genetic predisposition to alcoholic cirrhosis and psychosis twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin. Exp. Res. 1981; 5: 207-15.
130. Bosron WF, Li TK: Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. [Review]. Hepatology 1986; 6: 502-510.
131. Day CP, Bashir R, James OFW, Bassendine ME, Crabb DW, Thomasson HR, Li TK, Edenberg HJ: Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology 1991; 14: 798-801.
132. Poupon RE, Nalpas B, Coutelle C, Fleury B, Couzigou P, Higueret D: Polymorphism of alcohol dehydrogenase, alcohol and aldehyde dehydrogenase activities: implication in alcoholic cirrhosis in white patients. Hepatology 1992; 15: 1017-1022.
133. Hayashi S, Watanabe J, Kawajiri K: Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem. 1991; 110: 559-65.
134. Tsutsumi M, Takada A, Wang J, Takase S: Genetic polymorphisms of cytochrome P4502E1 related to the developement of alcoholic liver disease. Hepatology 1993; 18: 124A.
135. Enomoto N, Takase S, Takada N, Takada A: Alcoholic liver disease in heterozygotes of mutant and normal aldehyde dehydrogenase-2 genes. Hepatology 1991; 13: 1071-1075.
136. Casini A, Ceni E, Salzano K, Crabb DW, Ingelman-Sundberg M, Surrenti C: Expression of aldehyde dehydrogenase-2 (ALDH2) and cytochrome P-4502E1 (CYP2E1) genes in human liver modulates different susceptibility to alcoholic liver disease. J. Hepatol. 1994; 21(Suppl 1): S15
137. Bjorneboe A, Bjorneboe G-EA: Antioxidant status and alcohol-related diseases. Alcohol Alcohol 1993; 28: 111-116.
138. Morimoto M, Hagbjork AL, Nanji AA, Ingelman-Sundberg M, Lindros KO, Fu PC, Albano E, French SW: Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol 1993; 10: 459-464.
139. Rotily M, Durbec JP, Berthezene P, Sarles H: Diet and alcohol in liver cirrhosis: a case-control study. Eur. J. Clin. Nutr. 1990; 44: 595-603.
140. Takahashi H, Wong K, Jui L, Nanji AA, Mendenhall CS, French SW: Effect of dietary fat on Ito cell activation by chronic ethanol intake: a long-term serial morphometric study on alcohol-fed and control rats. Alcohol Clin. Exp. Res. 1991; 15: 1060-1066.
141. Matsuoka M, Zhang MY, Tsukamoto H: Sensitization of hepatic lipocytes by high-fat diet to stimulatory effects of Kupffer cell-derived factors: implications in alcoholic liver fibrogenesis. Hepatology 1990; 11: 173-182.
142. French SW: Nutrition in the pathogenesis of alcoholic liver disease. Alcohol Alcohol 1993; 28: 97-109.
143. Tsutsumi M, Lasker JM, Shimizu M, Rosman AS, Lieber CS: The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 1989; 10: 437-446.
144. Buehler R, Hess M, Von Wartburg JP: Immunohistochemical localization of human liver alcohol dehydrogenase in liver tissue, cultured fibroblasts, and HeLa cells. Am. J. Pathol. 1982; 108: 89-99.
145. Jauhonen P, Baraona E, Miyakawa H, Lieber CS: Mechanism for selective perivenular hepatotoxicity of ethanol. Alcohol Clin. Exp. Res. 1982; 6: 350-357.
146. Videla L, Israel Y: Factors that modify the metabolism of ethanol in rat liver and adaptive changes produced by its chronic administration. Biochem. J. 1970; 118: 275-281.
147. Israel Y, Kalant H, Orrego H, Khanna JM, Videla L, Phillips JM: Experimental alcohol-induced hepatic necrosis: suppression by propylthiouracil. Proc. Natl. Acad. Sci. USA 1975; 72: 1137-1141.
148. Brunt P: The liver and alcohol. [Review]. J. Hepatol. 1988; 7: 377-383.
149. Stal P, Hulterantz R: Iron increases ethanol toxicity in rat liver. J. Hepatol. 1993; 17: 108-115.
150. Bassett ML, Halliday JW, Powell LW: Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6: 24-29.
151. LeSage GD, Baldus WP, Fairbanks VF, Baggenstoss AH, McCall JT, Moore SR, Taswell HF, Gordon H: Hemochromatosis: genetic or alcohol-induced? Gastroenterology 1983; 84: 1471-1477.
152. Hann HL, Yang S, Tran LP, Hann CL, Rubin R: Cross time study of lipid peroxidation under the influence of alcohol and iron. Hepatology 1994; 20: 315A.
153. Letteron P, Duchatelle V, Berson A, Fromenty B, Fisch C, Degott C, Benhamou JP, Pessayre D: Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers. Gut 1993; 34: 409-14.
154. Pietrangelo A, Gualdi R, Casalgrandi G, Montosi G, Ventura E: Vitamin E prevents hepatic cirrhosis during experimental iron overload by blocking a mitogenic effect of iron on liver nonparenchymal cells. J. Hepatol. 1994; 21(Suppl 1): S11
155. Gasso M, Cabballeria J, Cabre M, Corrales F, Rubio M, Deulofeu A, Giminez A, Pares A, Camps J, Ballesta AM, Mato JM, Rodes J: Influence of s-adenosylmethionine (SAMe) on lipid peroxidation and liver fibrogenesis in CC14-induced cirrhosis. J. Hepatol. 1994; 21(Suppl 1): S3